Blueprint Medicines CorporationBlueprint Medicines CorporationBlueprint Medicines Corporation

Blueprint Medicines Corporation

No trades
See on Supercharts

Price target

98.000.00 0.00%
The 16 analysts offering 1 year price forecasts for BPMC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 17 analysts giving stock ratings to BPMC in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

BPMC EPS for the last quarter is −1.82 USD despite the estimation of −2.04 USD. In the next quarter EPS is expected to reach −1.67 USD. Track more of Blueprint Medicines Corporation financials and stay on top of what is up with the company.
In the next quarter Blueprint Medicines Corporation revenue is expected to reach ‪80.89 M‬ USD. Check out Blueprint Medicines Corporation revenue and earnings and make informed decisions.
According to analysts, BPMC price target is 98.00 USD with a max estimate of 130.00 USD and a min estimate of 50.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with BPMC news and stock market news.
We've gathered opinions of 17 analysts rating BPMC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.